SMTL ID : 3eah.1

Structure of inhibited human eNOS oxygenase domain

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.44 Å

Oligo State

homo-dimer

Ligands

2 x HEC: HEME C(Non-covalent)

HEC.1: 19 residues within 4Å: Chain A: W.113, A.116, R.118, C.119, V.120, Q.124, L.128, S.161, M.274, F.288, S.289, W.291, M.293, E.296, W.382, F.408, Y.410 Ligands: 327.3, MPD.6 20 PLIP interactions: 20 interactions with chain A, Hydrophobic interactions: A:W.113, A:W.113, A:W.113, A:A.116, A:R.118, A:V.120, A:Q.124, A:L.128, A:F.288, A:F.288, A:F.288, A:W.291, A:W.291, A:W.382, A:F.408, A:F.408, A:F.408 Hydrogen bonds: A:R.118 pi-Stacking: A:W.113 Metal complexes: A:C.119 HEC.10: 18 residues within 4Å: Chain B: W.113, A.116, R.118, C.119, V.120, G.121, Q.124, L.128, F.288, S.289, W.291, M.293, E.296, W.382, F.408, Y.410 Ligands: MPD.9, 327.11 21 PLIP interactions: 21 interactions with chain B, Hydrophobic interactions: B:W.113, B:W.113, B:W.113, B:A.116, B:R.118, B:V.120, B:Q.124, B:L.128, B:F.288, B:F.288, B:W.291, B:W.291, B:W.382, B:F.408, B:F.408, B:F.408 Hydrogen bonds: B:R.118, B:E.296, B:Y.410 pi-Stacking: B:W.113 Metal complexes: B:C.119

1 x ZN: ZINC ION(Non-covalent)

ZN.2: 4 residues within 4Å: Chain A: C.29, C.34 Chain B: C.29, C.34 4 PLIP interactions: 2 interactions with chain A, 2 interactions with chain B Metal complexes: A:C.29, A:C.34, B:C.29, B:C.34

2 x 327: (3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine(Non-covalent)

327.3: 9 residues within 4Å: Chain A: Q.182, P.269, V.271, S.289, G.290, W.291, E.296 Ligands: HEC.1, CL.5 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:V.271 Hydrogen bonds: A:E.296, A:E.296 327.11: 10 residues within 4Å: Chain B: Q.182, P.269, V.271, F.288, S.289, G.290, W.291, E.296 Ligands: CL.8, HEC.10 3 PLIP interactions: 3 interactions with chain B Hydrophobic interactions: B:F.288 Hydrogen bonds: B:E.296, B:E.296

4 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)

MPD.4: 9 residues within 4Å: Chain A: W.9, W.380, F.395, H.396, Q.397 Chain B: S.37, V.39, A.381, W.382 5 PLIP interactions: 3 interactions with chain B, 2 interactions with chain A Hydrophobic interactions: B:V.39, B:A.381, A:W.380, A:W.380 Hydrogen bonds: B:S.37 MPD.6: 7 residues within 4Å: Chain A: G.121, Q.124, W.291, V.353, A.358, S.361 Ligands: HEC.1 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:Q.124, A:W.291, A:A.358 MPD.7: 7 residues within 4Å: Chain A: V.39, A.381, W.382 Chain B: W.9, W.380, F.395, H.396 3 PLIP interactions: 2 interactions with chain A, 1 interactions with chain B Hydrophobic interactions: A:V.39, A:A.381, B:W.380 MPD.9: 7 residues within 4Å: Chain B: G.121, I.123, W.291, V.353, A.358, S.361 Ligands: HEC.10 5 PLIP interactions: 5 interactions with chain B Hydrophobic interactions: B:I.123, B:W.291, B:V.353, B:A.358 Hydrogen bonds: B:W.291

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.5: 5 residues within 4Å: Chain A: Q.182, Y.266, Y.292, N.301 Ligands: 327.3 Ligand excluded by PLIP CL.8: 4 residues within 4Å: Chain B: Y.266, Y.292, N.301 Ligands: 327.11 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Garcin, E.D. et al., Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase. Nat.Chem.Biol. (2008)

Release Date

2008-10-07

Peptides

Nitric oxide synthase, endothelial: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Nitric oxide synthase, endothelial

Related Entries With Identical Sequence